BriaCell Therapeutics

(TSX) BCT

Current PriceCA$5.03

Market CapCA$36.47M

Since IPO (2014)-100%

5 YearN/A

1 Year-89%

1 Month-9%

BriaCell Therapeutics Financials at a Glance

Market Cap

CA$36.47M

Revenue (TTM)

$0.00

Net Income (TTM)

-$29.62M

EPS (TTM)

-CA$38.83

P/E Ratio

-0.13

Dividend

CA$0.00

Beta (Volatility)

1.15 (Average)

Dividend

CA$0.00

Beta (Volatility)

1.15 (Average)

Price

CA$5.03

Volume

5,230

Open

CA$5.08

Price

CA$5.03

Volume

5,230

Open

CA$5.08

Previous Close

CA$5.03

Daily Range

CA$4.77 - CA$5.08

52-Week Range

CA$4.13 - CA$49.00

Dividend

CA$0.00

Beta (Volatility)

1.15 (Average)

Price

CA$5.03

Volume

5,230

Open

CA$5.08

Previous Close

CA$5.03

Daily Range

CA$4.77 - CA$5.08

52-Week Range

CA$4.13 - CA$49.00

BCT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About BriaCell Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

William V. Williams, MD

Website

www.briacell.com

Headquarters

West Vancouver, BC V7T 2X1, CA

BCT Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-175%

Return on Capital

-1%

Return on Assets

-88%

Earnings Yield

-7.69%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

CA$36.47M

Shares Outstanding

7.25M

Volume

5.23K

Avg. Volume

15.51K

Financials (TTM)

Gross Profit

-$107.93K

Operating Income

-$27.54M

EBITDA

-$27.43M

Operating Cash Flow

-$28.51M

Capital Expenditure

$0.00

Free Cash Flow

-$28.51M

Cash & ST Invst.

$17.93M

Total Debt

$0.00

BriaCell Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

CA$36.47M

N/A

Market Cap/Employee

CA$2.28M

N/A

Employees

N/A

Net Income

-$7.22M

-14.8%

EBITDA

-$7.50M

-5.1%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Net Cash

$29.65M

+502.2%

Accounts Receivable

$2.26M

+5.0%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-88.16%

N/A

Return on Invested Capital

-1.01%

N/A

Free Cash Flow

-$7.97M

-34.6%

Operating Cash Flow

-$7.97M

-34.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

MBX.TOMicrobix Biosystems Inc.

MBX.TOMicrobix Biosystems Inc.CA$0.27-1.82%

RVX.TOResverlogix Corp.

RVX.TOResverlogix Corp.CA$0.10-5.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCEVirgin Galactic

SPCEVirgin Galactic$6.18+0.36%

FFord Motor Company

FFord Motor Company$17.44+0.05%

ONDSOndas

ONDSOndas$13.22-0.00%

NOKNokia

NOKNokia$14.84-0.03%

BBAIBigBear.ai

BBAIBigBear.ai$5.04+0.02%

TAT&T

TAT&T$24.80-0.00%

HPEHewlett Packard Enterprise

HPEHewlett Packard Enterprise$43.04+0.13%

Questions About BCT

What is the current price of BriaCell Therapeutics?

BriaCell Therapeutics is trading at CA$5.03 per share.

What is the 52-week range for BriaCell Therapeutics?

Over the past 52 weeks, BriaCell Therapeutics has traded between CA$4.13 and CA$49.00.

How much debt does BriaCell Therapeutics have?

As of the most recent reporting period, BriaCell Therapeutics reported total debt of $0.00.

How much cash does BriaCell Therapeutics have on hand?

BriaCell Therapeutics reported $40.49M in cash and cash equivalents in its most recent financial results.

What is BriaCell Therapeutics’s dividend yield?

BriaCell Therapeutics does not currently have a dividend yield.

BriaCell Therapeutics

BriaCell Therapeutics Financials at a Glance

BCT News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About BriaCell Therapeutics

BCT Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

BriaCell Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BCT

What is the current price of BriaCell Therapeutics?

What is the 52-week range for BriaCell Therapeutics?

How much debt does BriaCell Therapeutics have?

How much cash does BriaCell Therapeutics have on hand?

What is BriaCell Therapeutics’s dividend yield?

Premium Investing Services